Elisabeth Engel from the Institute for Bioengineering of Catalonia (IBEC) and Professor at the Polytechnic University of Catalonia (UPC) appears in different media for the Dermoglass technology, the first project financed by the CaixaImpulse program to be licensed to a pharmaceutical company.
The Dermoglass product is based on particles that, when degrading, release oxygen and nutrients to the chronically ulcerated skin of people who are bedridden or in wheelchairs, so that the skin can regenerate. A dressing prototype is already available but now they want develop a cream, something that is expected within two years.
We started the project in 2015 and thanks to these programs we have been able to patent the particles, keep the patents and do the experiments on small animals.
Elisabeth Engel, group leader “Biomaterials for Regenerative Therapies” at IBEC
You can read the articles here: